Literature DB >> 16078134

Stochastic differential equations in NONMEM: implementation, application, and comparison with ordinary differential equations.

Christoffer W Tornøe1, Rune V Overgaard, Henrik Agersø, Henrik A Nielsen, Henrik Madsen, E Niclas Jonsson.   

Abstract

PURPOSE: The objective of the present analysis was to explore the use of stochastic differential equations (SDEs) in population pharmacokinetic/pharmacodynamic (PK/PD) modeling.
METHODS: The intra-individual variability in nonlinear mixed-effects models based on SDEs is decomposed into two types of noise: a measurement and a system noise term. The measurement noise represents uncorrelated error due to, for example, assay error while the system noise accounts for structural misspecifications, approximations of the dynamical model, and true random physiological fluctuations. Since the system noise accounts for model misspecifications, the SDEs provide a diagnostic tool for model appropriateness. The focus of the article is on the implementation of the Extended Kalman Filter (EKF) in NONMEM for parameter estimation in SDE models.
RESULTS: Various applications of SDEs in population PK/PD modeling are illustrated through a systematic model development example using clinical PK data of the gonadotropin releasing hormone (GnRH) antagonist degarelix. The dynamic noise estimates were used to track variations in model parameters and systematically build an absorption model for subcutaneously administered degarelix.
CONCLUSIONS: The EKF-based algorithm was successfully implemented in NONMEM for parameter estimation in population PK/PD models described by systems of SDEs. The example indicated that it was possible to pinpoint structural model deficiencies, and that valuable information may be obtained by tracking unexplained variations in parameters.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16078134     DOI: 10.1007/s11095-005-5269-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Population pharmacokinetics/pharmacodynamics modeling: parametric and nonparametric methods.

Authors:  R Jelliffe; A Schumitzky; M Van Guilder
Journal:  Ther Drug Monit       Date:  2000-06       Impact factor: 3.681

2.  Some statistical issues in modelling pharmacokinetic data.

Authors:  J K Lindsey; B Jones; P Jarvis
Journal:  Stat Med       Date:  2001 Sep 15-30       Impact factor: 2.373

3.  Grey-box pharmacokinetic/pharmacodynamic modelling of a euglycaemic clamp study.

Authors:  Christoffer Wenzel Tornøe; Judith L Jacobsen; Henrik Madsen
Journal:  J Math Biol       Date:  2003-12-02       Impact factor: 2.259

4.  A Bayesian approach to tracking patients having changing pharmacokinetic parameters.

Authors:  David S Bayard; Roger W Jelliffe
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-02       Impact factor: 2.745

5.  Grey-box modelling of pharmacokinetic/pharmacodynamic systems.

Authors:  Christoffer W Tornøe; Judith L Jacobsen; Oluf Pedersen; Torben Hansen; Henrik Madsen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-10       Impact factor: 2.745

6.  Non-linear mixed-effects models with stochastic differential equations: implementation of an estimation algorithm.

Authors:  Rune V Overgaard; Niclas Jonsson; Christoffer W Tornøe; Henrik Madsen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-02       Impact factor: 2.745

7.  Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report.

Authors:  V P Shah; K K Midha; S Dighe; I J McGilveray; J P Skelly; A Yacobi; T Layloff; C T Viswanathan; C E Cook; R D McDowall
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Oct-Dec       Impact factor: 2.441

8.  Three new residual error models for population PK/PD analyses.

Authors:  M O Karlsson; S L Beal; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1995-12

9.  The dosing solution influence on the pharmacokinetics of degarelix, a new GnRH antagonist, after s.c. administration to beagle dogs.

Authors:  Henrik Agersø; Wolfgang Koechling; Magnus Knutsson; Rolf Hjortkjaer; Mats O Karlsson
Journal:  Eur J Pharm Sci       Date:  2003-11       Impact factor: 4.384

10.  Population pharmacokinetic modeling of a subcutaneous depot for GnRH antagonist degarelix.

Authors:  Christoffer W Tornøe; Henrik Agersø; Henrik A Nielsen; Henrik Madsen; E Niclas Jonsson
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

  10 in total
  22 in total

1.  Using stochastic differential equations for PK/PD model development.

Authors:  Niels Rode Kristensen; Henrik Madsen; Steen Hvass Ingwersen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-02       Impact factor: 2.745

2.  A matlab framework for estimation of NLME models using stochastic differential equations: applications for estimation of insulin secretion rates.

Authors:  Stig B Mortensen; Søren Klim; Bernd Dammann; Niels R Kristensen; Henrik Madsen; Rune V Overgaard
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-06-15       Impact factor: 2.745

3.  Semiparametric mixed-effects analysis of PK/PD models using differential equations.

Authors:  Yi Wang; Kent M Eskridge; Shunpu Zhang
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-09-10       Impact factor: 2.745

4.  Reconstructing population exposures to environmental chemicals from biomarkers: challenges and opportunities.

Authors:  Panos G Georgopoulos; Alan F Sasso; Sastry S Isukapalli; Paul J Lioy; Daniel A Vallero; Miles Okino; Larry Reiter
Journal:  J Expo Sci Environ Epidemiol       Date:  2008-03-26       Impact factor: 5.563

5.  Approaches for modeling within subject variability in pharmacometric count data analysis: dynamic inter-occasion variability and stochastic differential equations.

Authors:  Chenhui Deng; Elodie L Plan; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-05-10       Impact factor: 2.745

6.  Handling interoccasion variability in model-based dose individualization using therapeutic drug monitoring data.

Authors:  João A Abrantes; Siv Jönsson; Mats O Karlsson; Elisabet I Nielsen
Journal:  Br J Clin Pharmacol       Date:  2019-04-29       Impact factor: 4.335

7.  Exact Gradients Improve Parameter Estimation in Nonlinear Mixed Effects Models with Stochastic Dynamics.

Authors:  Helga Kristin Olafsdottir; Jacob Leander; Joachim Almquist; Mats Jirstrand
Journal:  AAPS J       Date:  2018-08-01       Impact factor: 4.009

8.  Pharmacometrics models with hidden Markovian dynamics.

Authors:  Marc Lavielle
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-08-31       Impact factor: 2.745

9.  Predictive performance for population models using stochastic differential equations applied on data from an oral glucose tolerance test.

Authors:  Jonas B Møller; Rune V Overgaard; Henrik Madsen; Torben Hansen; Oluf Pedersen; Steen H Ingwersen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-12-16       Impact factor: 2.745

10.  Using spline-enhanced ordinary differential equations for PK/PD model development.

Authors:  Yi Wang; Kent Eskridge; Shunpu Zhang; Dong Wang
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-11-07       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.